Exogenous TGF-beta1 promotes stromal development in the heifer mammary gland.
The objectives of this study were to determine the local effects of transforming growth factor-beta1 (TGF-beta1) on mammary epithelial and stromal cell proliferation and expression of the TGF-beta1 responsive genes c-myc and fibronectin. A single slow-release plastic pellet containing 5 microg of TGF-beta1 and 20 mg of BSA was implanted in the parenchyma of the right rear quarter of the mammary gland of 9-mo-old prepubertal heifers. A control pellet containing 20 mg of BSA was implanted in the left rear quarter of each heifer. All heifers were treated with bromodeoxyuridine (BrdU) at 4, 12.5, and 22 h after the pellets were implanted to label proliferating cells. Two hours after the last BrdU injection, the animals were euthanatized, and their mammary glands were recovered. Proliferation of mammary stromal cells was significantly higher in TGF-beta1-treated quarters than in BSA-treated, control quarters (3.5 vs. 1.8% BrdU-positive cells). This result coincided with a lack of significant effect of TGF-beta1 on proliferation of mammary epithelial cells and apoptosis. By quantitative reverse transcriptase-polymerase chain reaction, we found that c-myc gene expression was unchanged after TGF-beta1 treatment, but fibronectin gene expression was increased 3-fold in TGF-beta1-treated quarters compared with BSA-treated, control quarters. Thus, we concluded that TGF-beta1 selectively acts on the stromal compartment of the bovine mammary gland by increasing cell proliferation and gene expression of the extracellular matrix protein fibronectin.
Musters
S
S
Department of Animal Science, University of Vermont, Burlington 05405, USA.
Coughlan
K
K
McFadden
T
T
Maple
R
R
Mulvey
T
T
Plaut
K
K
D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D001973:Bromodeoxyuridine / Q000008:administration & dosage / Q000032:analysis; D002417:Cattle / Q000254:growth & development; D002455:Cell Division / Q000187:drug effects; D004343:Drug Implants; D004847:Epithelial Cells / Q000166:cytology; D005260:Female; D005353:Fibronectins / Q000032:analysis / Q000235:genetics; D015870:Gene Expression; D007150:Immunohistochemistry; D020287:In Situ Nick-End Labeling; D007700:Kinetics; D008321:Mammary Glands, Animal / Q000166:cytology* / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012710:Serum Albumin, Bovine / Q000008:administration & dosage; D017154:Stromal Cells / Q000166:cytology*; D016212:Transforming Growth Factor beta / Q000494:pharmacology*; D053773:Transforming Growth Factor beta1
D004343:Drug Implants; D005353:Fibronectins; D016212:Transforming Growth Factor beta; D053773:Transforming Growth Factor beta1; D012710:Serum Albumin, Bovine; D001973:Bromodeoxyuridine